Inventage Lab, Inc. (389470.KQ) — Stock Score Summary

Inventage Lab, Inc. (389470.KQ) has a MoatMap StockRank of 5/100 based on Quality (23/100), Value (34/100), and Momentum (25/100) factor scores. The current signal is STRONG SELL.

Inventage Lab, Inc., a platform technology company, develops medicines using microfluidics-based drug delivery systems. The company was founded in 2015 and is based in Seongnam-si, South Korea.

Key Financial Metrics

Price$28.96
Market Cap$362M
Price/Book8.44
Return on Equity-7.9%
Return on Invested Capital-10.5%
Debt/Equity66.90
Gross Margin-128.5%
Operating Margin-2135.2%
Revenue Growth132.3%
Free Cash Flow$-12K

Inventage Lab, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is Inventage Lab, Inc.’s (389470.KQ) StockRank?
MoatMap’s StockRank for Inventage Lab, Inc. (389470.KQ) is 5/100, with a Strong Sell signal. It is a composite of Quality (23), Value (34), and Momentum (25) factor ranks across MoatMap’s 19,000+ stock universe.
Does Inventage Lab, Inc. have an economic moat?
Inventage Lab, Inc. (389470.KQ) has a Quality factor score of 23/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Inventage Lab, Inc. a buy, hold, or sell?
MoatMap’s current signal for Inventage Lab, Inc. (389470.KQ) is Strong Sell, based on a StockRank of 5/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Inventage Lab, Inc. in?
Inventage Lab, Inc. (389470.KQ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (South Korea).